MedPath

Multicentre REtrospective StuDy of Treatment and OUtComes in STEMI Patients in Fujian Province

Completed
Conditions
ST-segment Elevation Myocardial Infarction
Registration Number
NCT03763968
Lead Sponsor
Yan-song Guo
Brief Summary

This is a multicentre observational study planned to gather follow up data for a period of 1 year in order to understand the treatments and outcomes of ST-segment elevation myocardial infarction(STEMI) and improve medical care quality in Fujian province for China. Consecutive patients who were admitted and diagnosed with STEMI between January 2014 December 2018 were conducted at five regional representative hospitals in Fujian province, which included the Fujian Provincial Hospital,Longyan First Hospital, the affiliated hospital of putian university,the Second Affiliated Hospital of Fujian Medical University and Mindong Hospital of Ningde City.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
7000
Inclusion Criteria
  • STEMI patients with symptom onset within 30 days
Exclusion Criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
In-hospital mortality5years

all mortality,cardiovascular mortality

Secondary Outcome Measures
NameTimeMethod
other in-hospital complications5years

recurrent myocardial infarction, target vessel revascularization,contrast-induced acute kidney injury,stroke,bleeding,and so on

MACEs for long-term follow up1 year

mortality,stent restenosis, recurrent myocardial infarction, and target vessel revascularization,stroke,bleeding,and so on

Trial Locations

Locations (1)

Fujian Provincial

🇨🇳

Fuzhou, Fujian, China

© Copyright 2025. All Rights Reserved by MedPath